Related Experiment Video
Updated: Jul 12, 2026
13:45
Real-time Imaging of Leukotriene B4 Mediated Cell Migration and BLT1 Interactions with β-arrestin
Published on: December 23, 2010
Cytokine-leukotriene receptor interactions
Marek Rola-Pleszczynski1, Jana Stankova
1Immunology Division, Department of Pediatrics, Faculty of Medicine, Université de Sherbrooke, Sherbrooke QC, Canada. marek.rola-pleszczynski@usherbrooke.ca
Thescientificworldjournal
|September 4, 2007
Summary
Leukotrienes and cytokines are key inflammatory molecules with complex interactions. Understanding their communication pathways reveals new therapeutic targets for immune modulation.
Area of Science:
- Immunology
- Cell Biology
- Pharmacology
Background:
- Leukotrienes are lipid mediators involved in inflammation and immune responses.
- Cytokines are crucial for immune modulation and cell signaling.
- The interplay between leukotrienes and cytokines is complex and bidirectional.
Purpose of the Study:
- To elucidate the intricate relationship between leukotrienes and cytokines.
- To explore how these molecules influence cell-cell communication.
- To identify potential therapeutic strategies based on these interactions.
Main Methods:
- Biochemical analysis of leukotriene structure and synthesis pathways.
- Pharmacological studies on leukotriene receptor signaling.
- Investigation of cytokine-mediated effects on leukotriene receptor expression.
Main Results:
- Leukotrienes can induce the synthesis and release of specific cytokines.
- Cytokines modulate cellular sensitivity to leukotrienes by altering receptor expression.
- A complex network of cell-cell communication is mediated by these molecules.
Conclusions:
- The interaction between leukotrienes and cytokines is a critical aspect of inflammatory and immune processes.
- Further unraveling these interactions can lead to novel therapeutic interventions.
- This research opens new avenues in understanding cell-cell communication in immunity.
More Related Videos
Related Concept Videos
01:19Antiasthma Drugs: Leukotriene Modifiers
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
01:20The JAK-STAT Signaling Pathway
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
01:24T Cell Types and Functions
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
01:17Drugs Used in Lower Respiratory Disorders: Overview
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
01:28Asthma I: Introduction
Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...